A biotech start-up using nanotechnology for regenerative medicine, advanced therapies, drug discovery and 3D organoid cell culture, with an extensive patent portfolio. MICA is currently seeking Series A Venture investment to supercharge its clinical trials.
MICA Biosystems holds a diverse product/ therapy portfolio, reflecting an extensive R&D effort since its inception and founding by world-class researchers in the fields of biotechnology, cell engineering, regenerative medicine and bioengineering. The 3 main offerings, at differing stages of market approach, are listed below:
▸ MICA Cell Therapy; We use nanoparticles and an induced magnetic field to actively and accurately control the differentiation of stem cells in vivo in a highly location-specific, minimally-invasive procedure. MICA is currently pursuing clinical trials in Spinal Repair after successful preclinical trials in mammals, using this technology to aid in spinal fusion.
▸ Dynascreen™; The purpose of in vitro testing in drug screening is to mimic the in vivo environment as closely as possible. However, the majority of industry-standard tests are done in a static, unmoving environment where cells are not subjected to any mechanical forces, which does not reflect any in vivo environment. Dynascreen™ provides mechanical stimulation to cells in an assay as a bolt-on addition to existing instrumentation and methodologies. This low-cost, low-impact solution can be applied to a range of assays and is not cell-line specific, with incredible peer-reviewed data to prove its efficacy.
▸ MICA Bioreactor; We use a nanotechnology and magnetic forces to provide mechanical stimulation to cell cultures, facilitating 3D structure and organoid cell cultures, using our patented instrumentation.
Company Details
- Employees
- 8
- Founded
- 2011
- Address
- London, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Nanotechnology, Nanomedicine, Advanced Therapy, Stem Cell, Regenerative Medicine, Biotechnology, R&D, Cell Therapy, Drug Screening, Biomedicine, Biotechnology, Medicine.
- HQ
- London
Mica Biosystems Questions
Mica Biosystems's website is https://www.micabiosystems.co.uk/
Mica Biosystems's LinkedIn profile is https://uk.linkedin.com/company/mica-biosystems
Mica Biosystems has
8 employees.
View email and phone details for 8
employees at Mica Biosystems.
Mica Biosystems's industry is
Biotechnology Research
Mica Biosystems's top competitors are
West Midlands Health Tech Innovation Accelerator - Wmhtia,
Novableep,
Finallot,
Ademen Ltd,
Blackfish Biotech,
Keles,
Inocardia Limited,
Neuro-Bio Ltd,
Hanover 16,
Pingbit Health Limited.
Mica Biosystems's categories are Biotechnology Research
Mica Biosystems's founding year is 2011
